MarketCatalyst
← Back to Research
Recap

Cerebras Falls Below Its IPO Price as an OpenAI Scare Collides With Insider Selling

Cerebras shares fell below their $185 IPO price this week as a SemiAnalysis report questioning OpenAI's hardware choice collided with a major lockup expiration and tens of millions in insider stock sales — even as the company's $25.4 billion backlog gives some analysts reason to see the selloff as overdone.

5 min read

Shares of AI chipmaker Cerebras Systems ($CBRS) fell sharply this week, dropping below their $185 IPO price as three separate pressures — a customer-concentration scare, a major lockup expiration, and heavy insider selling — all landed within days of each other.

MetricFigure
IPO price (May 2026)$185
Sept. 30 single-day move-7% to -8.2%
Shares freed in Sept. 30 lockup wave~19.4–20 million
Officer Form 144 sale notices$84.3 million
Total backlog (as of June 30)$25.4 billion

The OpenAI displacement scare

The most consequential piece of news came from SemiAnalysis, which reported that OpenAI's newly unveiled GPT-6.1 Sol Ultrafast tier appears to be running on Nvidia GPUs — at low batch size and roughly 300 tokens per second — rather than on Cerebras hardware. That's a sharp drop from the 750 tokens per second Cerebras delivered powering the Ultrafast tier of the earlier GPT-5.6 Sol model. Neither OpenAI nor Cerebras has publicly confirmed which hardware actually serves the new tier.

The reason this particular rumor hit so hard: OpenAI is Cerebras' largest customer by revenue backlog, tied to a multi-year, 750-megawatt inference compute deal reportedly worth more than $20 billion. On Cerebras' August 12 earnings call, CEO Andrew Feldman said OpenAI would "stay a big part" of the business next year. Any sign that OpenAI is routing its newest, highest-profile model to a rival chipmaker instead reads as a direct threat to the customer-concentration story investors bought into at the IPO.

A lockup that releases in waves, not all at once

Unlike a typical single-date IPO lockup, Cerebras' unlocks on 11 separate dates, releasing an estimated 171 million shares in total across the first 10 waves, out of roughly 238 million shares outstanding. The September 30 wave freed an estimated 19.4 to 20 million shares into public float — one of several unlock dates that had already been chipping away at the stock in prior weeks, including a roughly 26% two-session drop following an earlier wave in June.

Executives filed to sell alongside the unlock

The lockup expiration landed the same day two senior officers filed Form 144 notices covering a combined $84.3 million in proposed stock sales. Separately, CTO Sean Lie reduced his direct holdings by nearly 28% in a $25.1 million sale, with CEO Andrew Feldman also selling multi-million-dollar tranches. Insiders have sold roughly $266 million in Cerebras stock over the trailing three months. A Form 144 filing discloses a proposed sale, not a confirmed completed one, but the timing — right as the lockup opened and the OpenAI rumor spread — added to investor unease.

The case that the selloff is overdone

Not every analyst is reading this as a structural problem. Cerebras' overall remaining performance obligations — the backlog of contracted work not yet delivered — stood at $25.4 billion as of June 30, and the company has continued signing new inference partnerships beyond OpenAI, including deals with cloud startups Gimlet Labs and General Compute, broadening its customer base somewhat beyond its original anchor client. Bulls argue that a single unverified hardware report, even about Cerebras' biggest customer, shouldn't by itself undo a multi-billion-dollar backlog built across several customers.

What to watch. A direct statement from OpenAI or Cerebras confirming which hardware actually powers GPT-6.1 Sol Ultrafast would go a long way toward resolving the bigger of the two concerns. Until then, the stock remains caught between a backlog bulls see as underappreciated and a concentration risk bears see as newly confirmed.

MarketCatalyst LLC is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.

Cerebras Falls Below Its IPO Price as an OpenAI Scare Collides With Insider Selling